Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls

Tau protein is consistently reported to be elevated in cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD). CSF tau alone, however, is not a clinically useful diagnostic marker due to its relatively low diagnostic specificity. Therefore, efforts are under way to combine tau meas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience letters 1999-12, Vol.277 (1), p.21-24
Hauptverfasser: Bürger née Buch, Katharina, Padberg, Frank, Nolde, Tom, Teipel, Stefan J, Stübner, Susanne, Haslinger, Andreas, Schwarz, Markus J, Sunderland, Trey, Arai, Hiroyuki, Rapoport, Stanley I, Möller, Hans-Jürgen, Hampel, Harald
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 24
container_issue 1
container_start_page 21
container_title Neuroscience letters
container_volume 277
creator Bürger née Buch, Katharina
Padberg, Frank
Nolde, Tom
Teipel, Stefan J
Stübner, Susanne
Haslinger, Andreas
Schwarz, Markus J
Sunderland, Trey
Arai, Hiroyuki
Rapoport, Stanley I
Möller, Hans-Jürgen
Hampel, Harald
description Tau protein is consistently reported to be elevated in cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD). CSF tau alone, however, is not a clinically useful diagnostic marker due to its relatively low diagnostic specificity. Therefore, efforts are under way to combine tau measurements with other criteria in order to improve diagnostic applicability. We investigated whether age could serve as an useful criterion to increase diagnostic accuracy. CSF levels of tau were measured in young old (
doi_str_mv 10.1016/S0304-3940(99)00845-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69408322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304394099008459</els_id><sourcerecordid>69408322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-88613fd30bcbc7a47b9eda7cef35b8c84212226046659c33badbf1cca980f3fe3</originalsourceid><addsrcrecordid>eNqFkd-O1CAUh4nRuOPqI2i4MLp7UYVCCySbmM3Ef8kmXqjXhMKpg2nLCNTN-DK-qnQ6Ue_2gpDAdw6c34fQU0peUULb158JI7xiipMLpS4Jkbyp1D20oVLUlVCivo82f5Ez9Cil74SQhjb8ITqjpOVMSrlBv7cQoYsh7f1kBtwPs3c4mxnvY8jgJ5x24TZhgzvIGSJ2PtnoxwJnHyZcgEOYp284DA5fXAmCD2BiusR5Z463y_my9oWHKSd86_MOXw-_duBHiC_T0hFMAmzDuDcR3ErYMOUYhvQYPejNkODJaT9HX9-9_bL9UN18ev9xe31TWS5YrqRsKesdI53trDBcdAqcERZ61nTSSl7Tuq5bwtu2UZaxzriup9YaJUnPemDn6MXat8z9Y4aU9VgmhWEwE4Q56bakKFld3wlSwRvOFClgs4K2pJsi9HpfgjPxoCnRi0J9VKgXP1opfVSoVal7dnpg7kZw_1Wtzgrw_ASYZM3QRzNZn_5xVIlWtQV7s2JQYvvpIepkiwILzkewWbvg7_jJH74euwo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17454390</pqid></control><display><type>article</type><title>Cerebrospinal fluid tau protein shows a better discrimination in young old (&lt;70 years) than in old old patients with Alzheimer's disease compared with controls</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Bürger née Buch, Katharina ; Padberg, Frank ; Nolde, Tom ; Teipel, Stefan J ; Stübner, Susanne ; Haslinger, Andreas ; Schwarz, Markus J ; Sunderland, Trey ; Arai, Hiroyuki ; Rapoport, Stanley I ; Möller, Hans-Jürgen ; Hampel, Harald</creator><creatorcontrib>Bürger née Buch, Katharina ; Padberg, Frank ; Nolde, Tom ; Teipel, Stefan J ; Stübner, Susanne ; Haslinger, Andreas ; Schwarz, Markus J ; Sunderland, Trey ; Arai, Hiroyuki ; Rapoport, Stanley I ; Möller, Hans-Jürgen ; Hampel, Harald</creatorcontrib><description>Tau protein is consistently reported to be elevated in cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD). CSF tau alone, however, is not a clinically useful diagnostic marker due to its relatively low diagnostic specificity. Therefore, efforts are under way to combine tau measurements with other criteria in order to improve diagnostic applicability. We investigated whether age could serve as an useful criterion to increase diagnostic accuracy. CSF levels of tau were measured in young old (&lt;70 years) and old old (≥70 years) patients with probable AD, elderly patients with major depression (MD), and age-matched healthy controls (HC). In AD patients, CSF tau levels were significantly elevated compared with MD patients and HC ( P&lt;0.001). Based on a previously established cut-off of 260 pg/ml, the discriminative power was higher in the young old than in the old old subjects. Similarly, receiver operating characteristics analysis revealed a statistically significant higher correct classification rate in the young old. Our findings indicate that the discriminative power of CSF tau is higher in the young than in the old old. We suggest that the effect of age should be considered in studies investigating CSF tau as a diagnostic marker for neurodegenerative disorders.</description><identifier>ISSN: 0304-3940</identifier><identifier>EISSN: 1872-7972</identifier><identifier>DOI: 10.1016/S0304-3940(99)00845-9</identifier><identifier>PMID: 10643888</identifier><identifier>CODEN: NELED5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Age ; Age Distribution ; Aged ; Aged, 80 and over ; Alzheimer Disease - cerebrospinal fluid ; Alzheimer Disease - physiopathology ; Alzheimer’s disease ; Biological and medical sciences ; Cerebrospinal fluid ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Diagnosis ; Discriminative power ; Female ; Humans ; Major depression ; Male ; Medical sciences ; Middle Aged ; Neurology ; tau Proteins - cerebrospinal fluid ; Tau-protein</subject><ispartof>Neuroscience letters, 1999-12, Vol.277 (1), p.21-24</ispartof><rights>1999 Elsevier Science Ireland Ltd</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-88613fd30bcbc7a47b9eda7cef35b8c84212226046659c33badbf1cca980f3fe3</citedby><cites>FETCH-LOGICAL-c473t-88613fd30bcbc7a47b9eda7cef35b8c84212226046659c33badbf1cca980f3fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304394099008459$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1197696$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10643888$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bürger née Buch, Katharina</creatorcontrib><creatorcontrib>Padberg, Frank</creatorcontrib><creatorcontrib>Nolde, Tom</creatorcontrib><creatorcontrib>Teipel, Stefan J</creatorcontrib><creatorcontrib>Stübner, Susanne</creatorcontrib><creatorcontrib>Haslinger, Andreas</creatorcontrib><creatorcontrib>Schwarz, Markus J</creatorcontrib><creatorcontrib>Sunderland, Trey</creatorcontrib><creatorcontrib>Arai, Hiroyuki</creatorcontrib><creatorcontrib>Rapoport, Stanley I</creatorcontrib><creatorcontrib>Möller, Hans-Jürgen</creatorcontrib><creatorcontrib>Hampel, Harald</creatorcontrib><title>Cerebrospinal fluid tau protein shows a better discrimination in young old (&lt;70 years) than in old old patients with Alzheimer's disease compared with controls</title><title>Neuroscience letters</title><addtitle>Neurosci Lett</addtitle><description>Tau protein is consistently reported to be elevated in cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD). CSF tau alone, however, is not a clinically useful diagnostic marker due to its relatively low diagnostic specificity. Therefore, efforts are under way to combine tau measurements with other criteria in order to improve diagnostic applicability. We investigated whether age could serve as an useful criterion to increase diagnostic accuracy. CSF levels of tau were measured in young old (&lt;70 years) and old old (≥70 years) patients with probable AD, elderly patients with major depression (MD), and age-matched healthy controls (HC). In AD patients, CSF tau levels were significantly elevated compared with MD patients and HC ( P&lt;0.001). Based on a previously established cut-off of 260 pg/ml, the discriminative power was higher in the young old than in the old old subjects. Similarly, receiver operating characteristics analysis revealed a statistically significant higher correct classification rate in the young old. Our findings indicate that the discriminative power of CSF tau is higher in the young than in the old old. We suggest that the effect of age should be considered in studies investigating CSF tau as a diagnostic marker for neurodegenerative disorders.</description><subject>Age</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alzheimer Disease - cerebrospinal fluid</subject><subject>Alzheimer Disease - physiopathology</subject><subject>Alzheimer’s disease</subject><subject>Biological and medical sciences</subject><subject>Cerebrospinal fluid</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Diagnosis</subject><subject>Discriminative power</subject><subject>Female</subject><subject>Humans</subject><subject>Major depression</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>tau Proteins - cerebrospinal fluid</subject><subject>Tau-protein</subject><issn>0304-3940</issn><issn>1872-7972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd-O1CAUh4nRuOPqI2i4MLp7UYVCCySbmM3Ef8kmXqjXhMKpg2nLCNTN-DK-qnQ6Ue_2gpDAdw6c34fQU0peUULb158JI7xiipMLpS4Jkbyp1D20oVLUlVCivo82f5Ez9Cil74SQhjb8ITqjpOVMSrlBv7cQoYsh7f1kBtwPs3c4mxnvY8jgJ5x24TZhgzvIGSJ2PtnoxwJnHyZcgEOYp284DA5fXAmCD2BiusR5Z463y_my9oWHKSd86_MOXw-_duBHiC_T0hFMAmzDuDcR3ErYMOUYhvQYPejNkODJaT9HX9-9_bL9UN18ev9xe31TWS5YrqRsKesdI53trDBcdAqcERZ61nTSSl7Tuq5bwtu2UZaxzriup9YaJUnPemDn6MXat8z9Y4aU9VgmhWEwE4Q56bakKFld3wlSwRvOFClgs4K2pJsi9HpfgjPxoCnRi0J9VKgXP1opfVSoVal7dnpg7kZw_1Wtzgrw_ASYZM3QRzNZn_5xVIlWtQV7s2JQYvvpIepkiwILzkewWbvg7_jJH74euwo</recordid><startdate>19991217</startdate><enddate>19991217</enddate><creator>Bürger née Buch, Katharina</creator><creator>Padberg, Frank</creator><creator>Nolde, Tom</creator><creator>Teipel, Stefan J</creator><creator>Stübner, Susanne</creator><creator>Haslinger, Andreas</creator><creator>Schwarz, Markus J</creator><creator>Sunderland, Trey</creator><creator>Arai, Hiroyuki</creator><creator>Rapoport, Stanley I</creator><creator>Möller, Hans-Jürgen</creator><creator>Hampel, Harald</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19991217</creationdate><title>Cerebrospinal fluid tau protein shows a better discrimination in young old (&lt;70 years) than in old old patients with Alzheimer's disease compared with controls</title><author>Bürger née Buch, Katharina ; Padberg, Frank ; Nolde, Tom ; Teipel, Stefan J ; Stübner, Susanne ; Haslinger, Andreas ; Schwarz, Markus J ; Sunderland, Trey ; Arai, Hiroyuki ; Rapoport, Stanley I ; Möller, Hans-Jürgen ; Hampel, Harald</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-88613fd30bcbc7a47b9eda7cef35b8c84212226046659c33badbf1cca980f3fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Age</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alzheimer Disease - cerebrospinal fluid</topic><topic>Alzheimer Disease - physiopathology</topic><topic>Alzheimer’s disease</topic><topic>Biological and medical sciences</topic><topic>Cerebrospinal fluid</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Diagnosis</topic><topic>Discriminative power</topic><topic>Female</topic><topic>Humans</topic><topic>Major depression</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>tau Proteins - cerebrospinal fluid</topic><topic>Tau-protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bürger née Buch, Katharina</creatorcontrib><creatorcontrib>Padberg, Frank</creatorcontrib><creatorcontrib>Nolde, Tom</creatorcontrib><creatorcontrib>Teipel, Stefan J</creatorcontrib><creatorcontrib>Stübner, Susanne</creatorcontrib><creatorcontrib>Haslinger, Andreas</creatorcontrib><creatorcontrib>Schwarz, Markus J</creatorcontrib><creatorcontrib>Sunderland, Trey</creatorcontrib><creatorcontrib>Arai, Hiroyuki</creatorcontrib><creatorcontrib>Rapoport, Stanley I</creatorcontrib><creatorcontrib>Möller, Hans-Jürgen</creatorcontrib><creatorcontrib>Hampel, Harald</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bürger née Buch, Katharina</au><au>Padberg, Frank</au><au>Nolde, Tom</au><au>Teipel, Stefan J</au><au>Stübner, Susanne</au><au>Haslinger, Andreas</au><au>Schwarz, Markus J</au><au>Sunderland, Trey</au><au>Arai, Hiroyuki</au><au>Rapoport, Stanley I</au><au>Möller, Hans-Jürgen</au><au>Hampel, Harald</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cerebrospinal fluid tau protein shows a better discrimination in young old (&lt;70 years) than in old old patients with Alzheimer's disease compared with controls</atitle><jtitle>Neuroscience letters</jtitle><addtitle>Neurosci Lett</addtitle><date>1999-12-17</date><risdate>1999</risdate><volume>277</volume><issue>1</issue><spage>21</spage><epage>24</epage><pages>21-24</pages><issn>0304-3940</issn><eissn>1872-7972</eissn><coden>NELED5</coden><abstract>Tau protein is consistently reported to be elevated in cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD). CSF tau alone, however, is not a clinically useful diagnostic marker due to its relatively low diagnostic specificity. Therefore, efforts are under way to combine tau measurements with other criteria in order to improve diagnostic applicability. We investigated whether age could serve as an useful criterion to increase diagnostic accuracy. CSF levels of tau were measured in young old (&lt;70 years) and old old (≥70 years) patients with probable AD, elderly patients with major depression (MD), and age-matched healthy controls (HC). In AD patients, CSF tau levels were significantly elevated compared with MD patients and HC ( P&lt;0.001). Based on a previously established cut-off of 260 pg/ml, the discriminative power was higher in the young old than in the old old subjects. Similarly, receiver operating characteristics analysis revealed a statistically significant higher correct classification rate in the young old. Our findings indicate that the discriminative power of CSF tau is higher in the young than in the old old. We suggest that the effect of age should be considered in studies investigating CSF tau as a diagnostic marker for neurodegenerative disorders.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>10643888</pmid><doi>10.1016/S0304-3940(99)00845-9</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3940
ispartof Neuroscience letters, 1999-12, Vol.277 (1), p.21-24
issn 0304-3940
1872-7972
language eng
recordid cdi_proquest_miscellaneous_69408322
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Age
Age Distribution
Aged
Aged, 80 and over
Alzheimer Disease - cerebrospinal fluid
Alzheimer Disease - physiopathology
Alzheimer’s disease
Biological and medical sciences
Cerebrospinal fluid
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Diagnosis
Discriminative power
Female
Humans
Major depression
Male
Medical sciences
Middle Aged
Neurology
tau Proteins - cerebrospinal fluid
Tau-protein
title Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T19%3A38%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cerebrospinal%20fluid%20tau%20protein%20shows%20a%20better%20discrimination%20in%20young%20old%20(%3C70%20years)%20than%20in%20old%20old%20patients%20with%20Alzheimer's%20disease%20compared%20with%20controls&rft.jtitle=Neuroscience%20letters&rft.au=B%C3%BCrger%20n%C3%A9e%20Buch,%20Katharina&rft.date=1999-12-17&rft.volume=277&rft.issue=1&rft.spage=21&rft.epage=24&rft.pages=21-24&rft.issn=0304-3940&rft.eissn=1872-7972&rft.coden=NELED5&rft_id=info:doi/10.1016/S0304-3940(99)00845-9&rft_dat=%3Cproquest_cross%3E69408322%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17454390&rft_id=info:pmid/10643888&rft_els_id=S0304394099008459&rfr_iscdi=true